A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effect of Romiplostim on Health-Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents

Background Chronic immune thrombocytopenia (ITP) in children can negatively impact their health‐related quality of life (HRQoL) and impose a burden on their parents. This study sought to examine the effect of romiplostim on HRQoL and parental burden in children with primary ITP. Procedure This was a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2016-07, Vol.63 (7), p.1232-1237
Hauptverfasser:	Mathias, Susan D., Li, Xiaoyan, Eisen, Melissa, Carpenter, Nancy, Crosby, Ross D., Blanchette, Victor S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Child Child, Preschool Cost of Illness Double-Blind Method Female health-related quality of life Hematology Humans kids' ITP tools Male minimally important difference Oncology parental burden Parents Parents & parenting pediatric immune thrombocytopenia Pediatrics Purpura, Thrombocytopenic, Idiopathic - drug therapy Quality of Life Receptors, Fc - administration & dosage Recombinant Fusion Proteins - administration & dosage Recombinant Fusion Proteins - adverse effects romiplostim Thrombopoietin - administration & dosage Thrombopoietin - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Chronic immune thrombocytopenia (ITP) in children can negatively impact their health‐related quality of life (HRQoL) and impose a burden on their parents. This study sought to examine the effect of romiplostim on HRQoL and parental burden in children with primary ITP. Procedure This was a phase 3, randomized, double‐blind, placebo‐controlled study. Children aged
ISSN:	1545-5009 1545-5017
DOI:	10.1002/pbc.25984